Phase II Study of the Combination of Abemaciclib and Pembrolizumab in Locally Advanced Unresectable or Metastatic Gastroesophageal Adenocarcinoma: Big Ten Cancer Research Consortium BTCRC-GI18-149

Learn more:

• clinicaltrials.gov: #NCT03997448
• See Study Locations on Big Ten CRC Website